New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report

...ates with OraSure II-65 Pro-Pharmaceuticals to Collaborate with Digna Biotech II-65 Medivir and Tibotec Establish Collaboration Deal II-66 vgx Extends Collaboration with University of Pennsylvania II-66 Presidio Wins Exclusive License to Novel HCV Technology II-66 Roche Inks Licensing...

Hepatitis C Therapeutic DNA Vaccine Delivered by Inovio Biomedical's Electroporation Technology Reduces Viral Load by Up to 99.7% : Clinical Data Presented at Annual Scientific Meeting of the American Association for the Study of Liver Diseases

...nology is protected by an extensive patent portfolio covering in vivo electroporation. The company has entered into a definitive merger agreement with vgx Pharmaceuticals. More information is available at www.inovio.com . This press release contains certain forward-looking statements relating to o...

Therapeutic DNA Vaccine Company Inovio Biomedical Reports Second Quarter 2008 Financial Results

... execution of the definitive merger agreement with vgx Pharmaceuticals, Inc., announced July 7, 2008. ... the signing of a definitive merger agreement with vgx Pharmaceuticals, Inc., a privately-held DNA vaccin... exchange for all of the outstanding securities of vgx Pharmaceuticals, subject to completion of the regi...

Gene therapy improves survival and quality of life of dogs with cancer

...cting common complications of cancer such as weakness, weight loss and anemia, said principal investigator Ruxandra Draghia-Akli, MD, PhD, researcher, vgx Pharmaceuticals Inc., The Woodlands, Tex. Such complications occur in more than 50 percent of patients with cancer and, along with loss of appetite...

Gene Therapy Helps Dogs Stricken With Cancer

...anemia, principal investigator Dr. Ruxandra Draghia-Akli, a researcher with vgx Pharmaceuticals Inc. in The Woodlands, Texas, said in a prepared statement...., such as vomiting and diarrhea, were greatly reduced, the study found. vgx Pharmaceuticals has applied to the U.S. Food and Drug Administration for pe...

VGX in Medical Technology

VGX Pharmaceuticals' Novel HIV and Pandemic Influenza DNA Vaccine Candidates Trigger Robust Immune Responses and Protection in Pre-Clinical Models

... MALAGA, Spain--(BUSINESS WIRE)--May 23, 2007 - vgx Pharmaceuticals' novel pandemic influenza vaccine ...onal Conference on DNA Vaccines in Malaga, Spain. vgx scientists created four synthetic consensus DNA va...u data was presented by Dr. Ruxandra Draghia-Akli, vgx Vice President, Immune Therapeutics Research. Se...

VGX in Biological Technology

GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results

...tting edge industrial method) for large scale production of the MVA viral vaccine. * In December 2008, GeoVax engaged the services of vgx International, Inc. (VGXI), whereby VGXI will manufacture plasmid (DNA) for use in GeoVax's future preventative and therapeutic clin...